Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373

Boosters of adjuvanted NVX-CoV2373 protein vaccine led to increasing neutralizing titers of antibody specific for the ancestral strain and omicron variants. Whether the elicited antibodies protect against infection is unclear.

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 388; no. 9; pp. 857 - 859
Main Authors Alves, Katia, Plested, Joyce S., Galbiati, Shirley, Chau, Gordon, Cloney-Clark, Shane, Zhu, Mingzhu, Kalkeri, Raj, Patel, Nita, Smith, Kathy, Marcheschi, Alex, Pfeiffer, Susan, McFall, Heather, Smith, Gale, Glenn, Gregory M., Dubovsky, Filip, Mallory, Raburn M.
Format Journal Article
LanguageEnglish
Published United States Massachusetts Medical Society 02.03.2023
Subjects
Cartography
Coronavirus
Coronaviruses
Correspondence
COVID-19 Vaccines - administration & dosage
COVID-19 Vaccines - immunology
Disease transmission
Humans
Immunogenicity
Immunogenicity, Vaccine - immunology
Infectious Disease
Proteins
Severe acute respiratory syndrome coronavirus 2
Software
Vaccines
Viral Infections
Online AccessGet full text

Cover

Abstract Boosters of adjuvanted NVX-CoV2373 protein vaccine led to increasing neutralizing titers of antibody specific for the ancestral strain and omicron variants. Whether the elicited antibodies protect against infection is unclear.
AbstractList Boosters of adjuvanted NVX-CoV2373 protein vaccine led to increasing neutralizing titers of antibody specific for the ancestral strain and omicron variants. Whether the elicited antibodies protect against infection is unclear.
Fourth Dose of SARS-CoV-2 Adjuvanted Protein VaccineBoosters of adjuvanted NVX-CoV2373 protein vaccine led to increasing neutralizing titers of antibody specific for the ancestral strain and omicron variants. Whether the elicited antibodies protect against infection is unclear.
Author Patel, Nita
Smith, Kathy
Marcheschi, Alex
Glenn, Gregory M.
Smith, Gale
Dubovsky, Filip
McFall, Heather
Kalkeri, Raj
Chau, Gordon
Plested, Joyce S.
Cloney-Clark, Shane
Zhu, Mingzhu
Pfeiffer, Susan
Alves, Katia
Galbiati, Shirley
Mallory, Raburn M.
Author_xml – sequence: 1
  givenname: Katia
  surname: Alves
  fullname: Alves, Katia
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 2
  givenname: Joyce S.
  surname: Plested
  fullname: Plested, Joyce S.
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 3
  givenname: Shirley
  surname: Galbiati
  fullname: Galbiati, Shirley
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 4
  givenname: Gordon
  surname: Chau
  fullname: Chau, Gordon
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 5
  givenname: Shane
  surname: Cloney-Clark
  fullname: Cloney-Clark, Shane
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 6
  givenname: Mingzhu
  surname: Zhu
  fullname: Zhu, Mingzhu
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 7
  givenname: Raj
  surname: Kalkeri
  fullname: Kalkeri, Raj
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 8
  givenname: Nita
  surname: Patel
  fullname: Patel, Nita
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 9
  givenname: Kathy
  surname: Smith
  fullname: Smith, Kathy
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 10
  givenname: Alex
  surname: Marcheschi
  fullname: Marcheschi, Alex
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 11
  givenname: Susan
  surname: Pfeiffer
  fullname: Pfeiffer, Susan
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 12
  givenname: Heather
  surname: McFall
  fullname: McFall, Heather
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 13
  givenname: Gale
  surname: Smith
  fullname: Smith, Gale
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 14
  givenname: Gregory M.
  surname: Glenn
  fullname: Glenn, Gregory M.
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 15
  givenname: Filip
  surname: Dubovsky
  fullname: Dubovsky, Filip
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
– sequence: 16
  givenname: Raburn M.
  surname: Mallory
  fullname: Mallory, Raburn M.
  email: rmallory@novavax.com
  organization: Novavax, Gaithersburg, MD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36734884$$D View this record in MEDLINE/PubMed
BookMark eNptkUtLxDAUhYMoOj52rqWgCxdWk5u0STaCjG98bFTchTZNxw5NMjat4L83w6ioeDd3cT8O59yzjpaddwahbYIPCc7yo7uz61sNQLIMyyU0IhmlKWM4X0YjjEGkjEu6htZDmOI4hMlVtEZzTpkQbITklbWD8xPjGt3074mvkyI590PXvySX3vrWT_wQklMfzPx29_Scjv0TUE430UpdtMFsfe4N9Hh-9jC-TG_uL67GJzepZoz0KTFlTYCWFVQ5FJqDzgVnheFScs0kl2WWMSwMlCbXmLNc1kCrDPMKagAOdAMdL3RnQ2lNpY3ru6JVs66xRfeufNGo3xfXvKiJf1NSSEIzEQX2PwU6_zqY0CvbBG3atnAmZlPAOSWEM8wiuvsHncZXuBgvUoKAgBzmjg4WlO58CJ2pv80QrOadqJ-dRHznZ4Bv-KuECOwtAGuDcmZq_9f5AEM8kQg
CitedBy_id crossref_primary_10_1038_s41541_024_00806_2
crossref_primary_10_1016_j_vaccine_2023_05_051
crossref_primary_10_1080_21645515_2023_2189885
crossref_primary_10_1016_j_vaccine_2024_02_037
crossref_primary_10_1093_infdis_jiad163
crossref_primary_10_1073_pnas_2313681121
crossref_primary_10_1128_jvi_01206_23
crossref_primary_10_1016_j_vaccine_2023_12_036
crossref_primary_10_1016_j_vaccine_2024_02_021
crossref_primary_10_1080_14760584_2023_2218913
Cites_doi 10.1038/s41598-021-03154-6
10.1101/2022.01.03.21268582
10.1016/S1473-3099(22)00420-0
10.1056/NEJMc1803554
ContentType Journal Article
Copyright Copyright © 2023 Massachusetts Medical Society. All rights reserved.
Copyright © 2023 Massachusetts Medical Society. All rights reserved. 2023 Massachusetts Medical Society
Copyright_xml – notice: Copyright © 2023 Massachusetts Medical Society. All rights reserved.
– notice: Copyright © 2023 Massachusetts Medical Society. All rights reserved. 2023 Massachusetts Medical Society
CorporateAuthor Novavax 2019nCoV-101 Study Group
CorporateAuthor_xml – name: Novavax 2019nCoV-101 Study Group
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
0TZ
7RV
7X7
7XB
8AO
8C1
8FE
8FH
8FI
ABUWG
AFKRA
AN0
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K0Y
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MBDVC
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1056/NEJMc2215509
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Pharma and Biotech Premium PRO
Nursing & Allied Health Database (ProQuest)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
Public Health Database (Proquest)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
ProQuest Central (Alumni)
ProQuest Central
British Nursing Database
ProQuest Central Essentials
Biological Science Collection
eLibrary
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
SciTech Premium Collection
New England Journal of Medicine
ProQuest Biological Science Collection
Family Health Database (Proquest)
Healthcare Administration Database
Medical Database
Psychology Database
ProQuest research library
Science Database (ProQuest)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest One Psychology
Pharma and Biotech Premium PRO
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
elibrary
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
New England Journal of Medicine
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest Family Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
MEDLINE - Academic
DatabaseTitleList
ProQuest One Psychology
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1533-4406
EndPage 859
ExternalDocumentID 10_1056_NEJMc2215509
36734884
NJ202303023880921
Genre Correspondence
Letter
GrantInformation Novavax
GrantInformation_xml – fundername: ;
GroupedDBID ---
-DZ
-ET
-~X
.-4
.55
.CO
.GJ
0R~
0WA
123
1VV
2KS
2WC
34G
36B
39C
4.4
5RE
7FN
7RV
7X7
85S
8C1
8W4
9M8
AACLI
AAEJM
AAIKC
AAMNW
AAQQT
AARDX
AAUTI
AAWTL
ABACO
ABEHJ
ABFLS
ABIVO
ABOCM
ABPPZ
ABPTK
ABQIJ
ABWJO
ACGFS
ACGOD
ACKOT
ACNCT
ACPFK
ACPRK
ACPVT
ACRZS
ADBBV
AENEX
AETEA
AFFNX
AFHKK
AFOSN
AFUVZ
AGFXO
AGNAY
AHMBA
AJJEV
AKALU
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
C45
CJ0
CS3
DCD
DU5
EBS
EX3
F5P
FD8
FM.
HCIFZ
HF~
HZ~
I4R
K-O
KOO
L7B
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MQT
MVM
N4W
NEJ
O9-
OK1
OMK
OVD
P-O
P2P
RHI
RWL
RXW
S10
SJN
TAE
TAF
TEORI
TN5
TWZ
UCV
UKR
UMD
VQA
W2G
WH7
WOQ
WOW
X7M
XJT
XYN
XZL
YCJ
YFH
YR2
YRY
YYP
YZZ
ZA5
ZCA
ZR0
ZVN
~KM
29N
53G
8AO
8FE
8FH
8FI
ABBLC
ABCQX
ABUWG
ADUKH
AERZD
AFKRA
AGHSJ
ALIPV
AN0
AQUVI
AZQEC
BCU
BKEYQ
BKNYI
BNQBC
BPHCQ
BVXVI
CCPQU
CGR
CUY
CVF
DWQXO
ECM
EIF
FYUFA
GNUQQ
GUQSH
LK8
NAPCQ
NPM
PCD
PQQKQ
PROAC
PSQYO
PSYQQ
SJFOW
TUQ
UIG
AAYXX
CITATION
HMCUK
UKHRP
0TZ
7XB
BEC
K0Y
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c441t-1ebf123bd2d62ac72c6874ae7997c4979b55408e2be6c07469f23d507d2f22723
IEDL.DBID 8C1
ISSN 0028-4793
IngestDate Tue Sep 17 21:30:38 EDT 2024
Wed Dec 04 15:09:44 EST 2024
Mon Nov 04 10:58:36 EST 2024
Fri Dec 06 04:10:02 EST 2024
Sat Sep 28 08:17:46 EDT 2024
Mon Mar 06 19:39:29 EST 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License http://www.nejmgroup.org/legal/terms-of-use.htm
This article is made available via the PMC Open Access Subset for unrestricted re-use, except commercial resale, and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the Covid-19 pandemic or until revoked in writing. Upon expiration of these permissions, PMC is granted a license to make this article available via PMC and Europe PMC, subject to existing copyright protections.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c441t-1ebf123bd2d62ac72c6874ae7997c4979b55408e2be6c07469f23d507d2f22723
Notes SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC9891358
PMID 36734884
PQID 2781282622
PQPubID 40644
PageCount 3
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9891358
proquest_miscellaneous_2773117404
proquest_journals_2781282622
crossref_primary_10_1056_NEJMc2215509
pubmed_primary_36734884
mms_nejm_10_1056_NEJMc2215509
PublicationCentury 2000
PublicationDate 2023-03-02
PublicationDateYYYYMMDD 2023-03-02
PublicationDate_xml – month: 03
  year: 2023
  text: 2023-03-02
  day: 02
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Boston
PublicationTitle The New England journal of medicine
PublicationTitleAlternate N Engl J Med
PublicationYear 2023
Publisher Massachusetts Medical Society
Publisher_xml – name: Massachusetts Medical Society
References Shinde, V, Fries, L, Wu, Y (r5) 2018; 378
Mallory, RM, Formica, N, Pfeiffer, S (r1) 2022; 22
Huang, Y, Borisov, O, Kee, JJ (r2) 2021; 11
van der Straten, K, Guerra, D, van Gils, MJ (r3) 2022
Glenn, GM (r4) 2022
e_1_3_4_3_2
e_1_3_4_2_2
e_1_3_4_6_2
e_1_3_4_5_2
e_1_3_4_4_2
References_xml – year: 2022
  ident: r3
  article-title: Mapping the antigenic diversification of SARS-CoV-2 ;(https://www.medrxiv.org/content/10.1101/2022.01.03.21268582v1)
  publication-title: preprint
  contributor:
    fullname: van Gils, MJ
– year: 2022
  ident: r4
  article-title: Vaccines and related biological products advisory committee ;(https://www.fda.gov/media/159498/download)
  publication-title: Food and Drug Administration ;Silver Spring, MD
  contributor:
    fullname: Glenn, GM
– volume: 11
  start-page: 23921
  year: 2021
  end-page: 23921
  ident: r2
  article-title: Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation.
  publication-title: Sci Rep
  contributor:
    fullname: Kee, JJ
– volume: 378
  start-page: 2346
  year: 2018
  end-page: 2348
  ident: r5
  article-title: Improved titers against influenza drift variants with a nanoparticle vaccine.
  publication-title: N Engl J Med
  contributor:
    fullname: Wu, Y
– volume: 22
  start-page: 1565
  year: 2022
  end-page: 1576
  ident: r1
  article-title: Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.
  publication-title: Lancet Infect Dis
  contributor:
    fullname: Pfeiffer, S
– ident: e_1_3_4_3_2
  doi: 10.1038/s41598-021-03154-6
– ident: e_1_3_4_5_2
– ident: e_1_3_4_4_2
  doi: 10.1101/2022.01.03.21268582
– ident: e_1_3_4_2_2
  doi: 10.1016/S1473-3099(22)00420-0
– ident: e_1_3_4_6_2
  doi: 10.1056/NEJMc1803554
SSID ssj0000149
Score 2.5281515
Snippet Boosters of adjuvanted NVX-CoV2373 protein vaccine led to increasing neutralizing titers of antibody specific for the ancestral strain and omicron variants....
Fourth Dose of SARS-CoV-2 Adjuvanted Protein VaccineBoosters of adjuvanted NVX-CoV2373 protein vaccine led to increasing neutralizing titers of antibody...
SourceID pubmedcentral
proquest
crossref
pubmed
mms
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 857
SubjectTerms Cartography
Coronavirus
Coronaviruses
Correspondence
COVID-19 Vaccines - administration & dosage
COVID-19 Vaccines - immunology
Disease transmission
Humans
Immunogenicity
Immunogenicity, Vaccine - immunology
Infectious Disease
Proteins
Severe acute respiratory syndrome coronavirus 2
Software
Vaccines
Viral Infections
SubjectTermsDisplay Coronavirus
Infectious Disease
Vaccines
Viral Infections
Title Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373
URI https://nejm.org/doi/full/10.1056/NEJMc2215509
https://www.ncbi.nlm.nih.gov/pubmed/36734884
https://www.proquest.com/docview/2781282622
https://search.proquest.com/docview/2773117404
https://pubmed.ncbi.nlm.nih.gov/PMC9891358
Volume 388
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9NADLfoJiFeEN8UtipI8Bit8SW5u6dpK6sKEhVCbOpbdF_RhtRk0PDAfz87vZYWAa_xRTrZPvt3ts8GeIuFLwqHnNX1mOaW7aA2dUrKZNE5lSvXd_ucl7PL_OOiWMSA2yqWVW5sYm-ofes4Rn6CklwRYWHE09vvKU-N4uxqHKExgMOMHR2_FJ9kO-2jIvyNEaRY-E4-_4QnzTtEBuh6zyUNlsvV39Dmn0WTO15o-ggeRviYnK3l_RjuheYJ3P8UE-RPQX_g9x4taQV96H4lbZ2YZEp_ddfJrF2ypaOrfvK-XQWmza8W6aS9QiHFM7icXnydzNI4HSF1BGG6NAu2JrdjPfoSjZPoSiVzE6TW0uVaaktIYawC2lA6niqiaxSe4J_HGlGieA4HTduEl5CYUJZeZc5Yo3I3dlZ5YTMj6rEvcmHFEN5tGFTdrptgVH3yuiirXUYO4Zi4VzXh2_If9KMNX6t4VFbVb8EO4c2WTErOmQvTBOIKrZEio7vTOB_Ci7UYthsRJTfoUUSRewLaLuAG2vuU5ua6b6StOUdbqFf_39ZreMAz5vvCMzyCg-7Hz3BMSKSzIxjIhRz1SjeCw_OL-ecvd_Zp2pc
link.rule.ids 230,314,780,784,885,12056,12223,21388,27924,27925,31719,31720,33266,33267,33744,33745,43310,43579,43805,73745,74014,74302
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9NADLdYJ8FeEN8rbBAkeIzW-pLc3ROCsaqDrUJom_oW3Vc0JjXZaHjYfz87vZYWAa_xRTrZjv27s_MzwDvMfZ475KquxzSzHAe1qVJyJovOqUy5ju1zUozPsy_TfBov3OaxrXIZE7tA7RvHd-QHKCkVERZG_HB9k_LUKK6uxhEaW7DNzOl5D7Y_HU2-fV8jkIoAON4hxdZ3yvoHPGveITJE1xtJaWs2m_8Nb_7ZNrmWh0aP4GEEkMnHhcUfw71QP4H7p7FE_hT0Mf_x0ZBf0IP2NmmqxCQjequ9TMbNjGMdHfaTz808sGxyMU0PmwsUUjyD89HR2eE4jfMRUkcgpk2HwVaUeKxHX6BxEl2hZGaC1Fq6TEttCSsMVEAbCsdzRXSFwhMA9FghShTPoVc3ddiFxISi8GrojDUqcwNnlRd2aEQ18HkmrOjD-6WCyusFDUbZla_zolxXZB_2SXtlHa5m_5DvLfVaxo9lXv42bR_ersTk5ly7MHUgrdAaKYZ0ehpkfXixMMNqI6Jgih5FErlhoNUCptDelNQ_Ljsqbc1V2ly9_P-23sCD8dnpSXlyPPn6CnZ44nzXhoZ70Gt__gr7hEta-zo63x1zVNyk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT9tADLZGkdBe0DZglMEWJHiMmvqS3N3TtAFVGVAhBKhv0f2K2KQmQLOH_ffzpdeundhe44t0sh37u_MXG-AIM5tlBn1V12Kcah8HpSpjciaNxohUmLbb5ygf3qXfxtk48J-mgVY5j4ltoLa18XfkPeSUiggLI_bKQIu4Ph18fnyK_QQpX2kN4zTWYJ2yYoIdWP96Nrq-WWomFcBwuE8KNHhCAD0_d94gerguVxLU2mQyfQl7_k2hXMpJgzewGcBk9GVm_bfwylXvYOMqlMu3QJ77vz9q8hF60PyK6jJS0YDeah6iYT3xcY8O_tFpPXVeNrofxyf1PTLOtuFucHZ7MozDrITYEKBp4r7TJSUhbdHmqAxHkwueKsel5CaVXGrCDYlwqF1u_IwRWSKzBAYtlogc2Q50qrpyuxApl-dW9I3SSqQmMVpYpvuKlYnNUqZZF47nCioeZy0xiraUneXFsiK7cEDaKyr3Y_IP-f5cr0X4cKbFHzN34XAhJpf3dQxVOdIKreGsTyepJO3C-5kZFhthuW_XI0jCVwy0WODbaa9Kqu8PbVtt6Su2mdj7_7Y-wQb5XXF5Prr4AK_98PmWkYb70Gmef7oDgiiN_hh87zfZmuDR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunogenicity+of+a+Fourth+Homologous+Dose+of+NVX-CoV2373&rft.jtitle=The+New+England+journal+of+medicine&rft.au=Alves%2C+Katia&rft.au=Plested%2C+Joyce+S&rft.au=Galbiati%2C+Shirley&rft.au=Chau%2C+Gordon&rft.date=2023-03-02&rft.eissn=1533-4406&rft.volume=388&rft.issue=9&rft.spage=857&rft_id=info:doi/10.1056%2FNEJMc2215509&rft_id=info%3Apmid%2F36734884&rft.externalDocID=36734884
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-4793&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-4793&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-4793&client=summon